Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Anna Stanhewicz, PhD · NCT05946785
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 28
- US sites recruiting
- 1
- Study start
- July 1, 2023
- Record last updated
- July 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.
Being studied: Acetylcholine; insulin aspart
Conditions: Gestational Diabetes; Vascular Endothelial Function
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
INCLUSION CRITERIA
- female sex
- 18 -50 years old
- pregnancy history within 5 years of the study visit
- had gestational diabetes diagnosed by their obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes
- or without a history of gestational diabetes
EXCLUSION CRITERIA
- skin diseases
- current tobacco/e-cigarette use
- diagnosed or suspected hepatic or metabolic disease including diabetes
- statin or other cholesterol-lowering medication
- current antihypertensive medication
- history of preeclampsia or gestational hypertension
- current pregnancy
- body mass index \<18.5 kg/m2
- allergy to materials used during the experiment.(e.g. latex), known allergies to study drugs.
Recruiting US locations
University of Iowa
Iowa City, IA 52242
Site contact: Anna Stanhewicz, PhD · 319-467-1732 · anna-stanhewicz@uiowa.edu
Study contacts (from the official record)
- Anna Reid-Stanhewicz, PHD · 319-467-1732 · anna-stanhewicz@uiowa.edu
Similar studies in Iowa
All diabetes studies in Iowa →- RecruitingHealthy volunteersEarly Phase 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersPhase 1
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Des Moines, IA + 55 other US sites
- Eligibility basics
- Ages 18–79